CareLit · DOI-Nachweis · Geburtshilfe und Frauenheilkunde
Tolerability of olaparib tablets as maintenance therapy in patients with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2/AGO-OVAR2.23 trial
DOI 10.1055/s-0038-1671027
Bibliografische Angaben
Nachweis in CareLit
Autor:innenLC Hanker, F Heitz, TW Park-Simon, M Gropp-Meier, B Ataseven, E Pujade-Lauraine, P Harter
ZeitschriftGeburtshilfe und Frauenheilkunde
Ausgabe10/2018
Jahrgang / SeitenJg. 78
Kernaussage aus der Literatur
Abstract-Vorschau
Tolerability of olaparib tablets as maintenance therapy in patients with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2/AGO-OVAR2.23 trial
Zitieren
Zitierempfehlung
LC Hanker, F Heitz, TW Park-Simon, M Gropp-Meier, B Ataseven, E Pujade-Lauraine, P Harter (2018) Tolerability of olaparib tablets as maintenance therapy in patients with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): Phase III SOLO2/AGO-OVAR2.23 trial. Geburtshilfe und Frauenheilkunde, 78 (10). https://doi.org/10.1055/s-0038-1671027
Mit CareLit weiterarbeiten